Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK

Objective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observe...

Full description

Saved in:
Bibliographic Details
Main Authors: Naru Morita, Toshio Hosaka, Atsuko Kitahara, Toshitaka Murashima, Hirohisa Onuma, Yoshikazu Sumitani, Kazuto Takahashi, Toshiaki Tanaka, Takuma Kondo, Hitoshi Ishida
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/9256482
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558096371679232
author Naru Morita
Toshio Hosaka
Atsuko Kitahara
Toshitaka Murashima
Hirohisa Onuma
Yoshikazu Sumitani
Kazuto Takahashi
Toshiaki Tanaka
Takuma Kondo
Hitoshi Ishida
author_facet Naru Morita
Toshio Hosaka
Atsuko Kitahara
Toshitaka Murashima
Hirohisa Onuma
Yoshikazu Sumitani
Kazuto Takahashi
Toshiaki Tanaka
Takuma Kondo
Hitoshi Ishida
author_sort Naru Morita
collection DOAJ
description Objective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observed the effects of AMPK activation on monocyte chemoattractant protein-1 (MCP-1) release in mature 3T3-L1 adipocytes. Methods. We observed signal transduction pathways regulating MCP-1, which increased in obese adipocytes, in an in vitro model of hypertrophied 3T3-L1 adipocytes preloaded with palmitate. Results. Palmitate-preloaded cells exhibited significant increase in MCP-1 release and triglyceride (TG) deposition. Increased MCP-1 release and TG deposition were significantly decreased by an AMPK activator. In addition, the AMPK activator not only markedly diminished MCP-1 secretion but also augmented phosphorylation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) 1/2. In contrast, MCP-1 release suppression was abolished by the AMPK inhibitor compound C and the MEK inhibitor U0126. Conclusions. MCP-1 release from hypertrophied adipocytes is suppressed by AMPK activation through the NF-κB and ERK pathways. These findings provide evidence that AMPK plays a crucial role in ameliorating obesity-induced inflammation.
format Article
id doaj-art-4c32905f13514fb9b63c945d784b61b8
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-4c32905f13514fb9b63c945d784b61b82025-02-03T01:33:12ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/92564829256482Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPKNaru Morita0Toshio Hosaka1Atsuko Kitahara2Toshitaka Murashima3Hirohisa Onuma4Yoshikazu Sumitani5Kazuto Takahashi6Toshiaki Tanaka7Takuma Kondo8Hitoshi Ishida9Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanThird Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo, JapanObjective. A growing body of evidence indicates that AMP-activated protein kinase (AMPK) contributes to not only energy metabolic homeostasis but also the inhibition of inflammatory responses. However, the underlying mechanisms remain unclear. To elucidate the role of AMPK, in this study, we observed the effects of AMPK activation on monocyte chemoattractant protein-1 (MCP-1) release in mature 3T3-L1 adipocytes. Methods. We observed signal transduction pathways regulating MCP-1, which increased in obese adipocytes, in an in vitro model of hypertrophied 3T3-L1 adipocytes preloaded with palmitate. Results. Palmitate-preloaded cells exhibited significant increase in MCP-1 release and triglyceride (TG) deposition. Increased MCP-1 release and TG deposition were significantly decreased by an AMPK activator. In addition, the AMPK activator not only markedly diminished MCP-1 secretion but also augmented phosphorylation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) 1/2. In contrast, MCP-1 release suppression was abolished by the AMPK inhibitor compound C and the MEK inhibitor U0126. Conclusions. MCP-1 release from hypertrophied adipocytes is suppressed by AMPK activation through the NF-κB and ERK pathways. These findings provide evidence that AMPK plays a crucial role in ameliorating obesity-induced inflammation.http://dx.doi.org/10.1155/2018/9256482
spellingShingle Naru Morita
Toshio Hosaka
Atsuko Kitahara
Toshitaka Murashima
Hirohisa Onuma
Yoshikazu Sumitani
Kazuto Takahashi
Toshiaki Tanaka
Takuma Kondo
Hitoshi Ishida
Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
Journal of Diabetes Research
title Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
title_full Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
title_fullStr Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
title_full_unstemmed Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
title_short Novel Mechanisms Modulating Palmitate-Induced Inflammatory Factors in Hypertrophied 3T3-L1 Adipocytes by AMPK
title_sort novel mechanisms modulating palmitate induced inflammatory factors in hypertrophied 3t3 l1 adipocytes by ampk
url http://dx.doi.org/10.1155/2018/9256482
work_keys_str_mv AT narumorita novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT toshiohosaka novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT atsukokitahara novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT toshitakamurashima novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT hirohisaonuma novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT yoshikazusumitani novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT kazutotakahashi novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT toshiakitanaka novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT takumakondo novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk
AT hitoshiishida novelmechanismsmodulatingpalmitateinducedinflammatoryfactorsinhypertrophied3t3l1adipocytesbyampk